These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 15972293)
1. Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. Szummer KE; Solomon SD; Velazquez EJ; Kilaru R; McMurray J; Rouleau JL; Mahaffey KW; Maggioni AP; Califf RM; Pfeffer MA; White HD; Eur Heart J; 2005 Oct; 26(20):2114-9. PubMed ID: 15972293 [TBL] [Abstract][Full Text] [Related]
2. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. Velazquez EJ; Francis GS; Armstrong PW; Aylward PE; Diaz R; O'Connor CM; White HD; Henis M; Rittenhouse LM; Kilaru R; van Gilst W; Ertl G; Maggioni AP; Spac J; Weaver WD; Rouleau JL; McMurray JJ; Pfeffer MA; Califf RM; Eur Heart J; 2004 Nov; 25(21):1911-9. PubMed ID: 15522470 [TBL] [Abstract][Full Text] [Related]
3. Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. Lewis EF; Velazquez EJ; Solomon SD; Hellkamp AS; McMurray JJ; Mathias J; Rouleau JL; Maggioni AP; Swedberg K; Kober L; White H; Dalby AJ; Francis GS; Zannad F; Califf RM; Pfeffer MA Eur Heart J; 2008 Mar; 29(6):748-56. PubMed ID: 18308687 [TBL] [Abstract][Full Text] [Related]
4. Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Berry C; Pieper KS; White HD; Solomon SD; Van de Werf F; Velazquez EJ; Maggioni AP; Califf RM; Pfeffer MA; McMurray JJ Eur Heart J; 2009 Jun; 30(12):1450-6. PubMed ID: 19346225 [TBL] [Abstract][Full Text] [Related]
5. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Steg PG; Dabbous OH; Feldman LJ; Cohen-Solal A; Aumont MC; López-Sendón J; Budaj A; Goldberg RJ; Klein W; Anderson FA; Circulation; 2004 Feb; 109(4):494-9. PubMed ID: 14744970 [TBL] [Abstract][Full Text] [Related]
6. Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. Ezekowitz JA; Kaul P; Bakal JA; Armstrong PW; Welsh RC; McAlister FA J Am Coll Cardiol; 2009 Jan; 53(1):13-20. PubMed ID: 19118718 [TBL] [Abstract][Full Text] [Related]
7. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290 [TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes. Segev A; Strauss BH; Tan M; Buller CE; Mendelsohn AA; Langer A; Goodman SG; Int J Cardiol; 2008 Sep; 129(2):233-7. PubMed ID: 17976842 [TBL] [Abstract][Full Text] [Related]
9. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Torabi A; Cleland JG; Khan NK; Loh PH; Clark AL; Alamgir F; Caplin JL; Rigby AS; Goode K Eur Heart J; 2008 Apr; 29(7):859-70. PubMed ID: 18353754 [TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. Yancy CW; Lopatin M; Stevenson LW; De Marco T; Fonarow GC; J Am Coll Cardiol; 2006 Jan; 47(1):76-84. PubMed ID: 16386668 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries). Segev A; Strauss BH; Tan M; Mendelsohn AA; Lai K; Ashton T; Fitchett D; Grima E; Langer A; Goodman SG; Am J Cardiol; 2006 Aug; 98(4):470-3. PubMed ID: 16893699 [TBL] [Abstract][Full Text] [Related]
12. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA; Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343 [TBL] [Abstract][Full Text] [Related]
13. Heart failure after acute coronary syndrome: identify to treat better! Rocha S; Nabais S; Magalhães S; Salgado A; Azevedo P; Torres M; Marques J; Pereira MA; Correia A Rev Port Cardiol; 2007 Apr; 26(4):349-59. PubMed ID: 17695730 [TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and long-term outcome in patients with heart failure complicating acute myocardial infarction]. Macín SM; Perna ER; Augier N; Cialzeta J; Farías EF; Fontana M; Agüero M; Badaracco JR Rev Esp Cardiol; 2005 Jul; 58(7):789-96. PubMed ID: 16022810 [TBL] [Abstract][Full Text] [Related]
15. Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Hasdai D; Topol EJ; Kilaru R; Battler A; Harrington RA; Vahanian A; Ohman EM; Granger CB; Van de Werf F; Simoons ML; O'connor CM; Holmes DR Am Heart J; 2003 Jan; 145(1):73-9. PubMed ID: 12514657 [TBL] [Abstract][Full Text] [Related]
16. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. Sampson UK; Pfeffer MA; McMurray JJ; Lokhnygina Y; White HD; Solomon SD; Eur Heart J; 2007 Mar; 28(6):685-91. PubMed ID: 16984929 [TBL] [Abstract][Full Text] [Related]
17. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: a pooled analysis of five registries. Abdulla J; Køber L; Abildstrøm SZ; Christensen E; James WP; Torp-Pedersen C Eur Heart J; 2008 Mar; 29(5):594-601. PubMed ID: 18270214 [TBL] [Abstract][Full Text] [Related]
18. Previous myocardial infarction as a risk factor for in-hospital cardiovascular outcomes (from the National Registry of Myocardial Infarction 4 and 5). Bui QT; Reddy VS; Jacobs JR; Begelman SM; Frederick PD; Miller DP; French WJ Am J Cardiol; 2013 Jun; 111(12):1694-700. PubMed ID: 23528029 [TBL] [Abstract][Full Text] [Related]
19. Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. Thomas KL; Al-Khatib SM; Lokhnygina Y; Solomon SD; Kober L; McMurray JJ; Califf RM; Velazquez EJ Am Heart J; 2008 Jan; 155(1):87-93. PubMed ID: 18082495 [TBL] [Abstract][Full Text] [Related]
20. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study. De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F; J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]